Table 2.
Demographic and clinical information for the full cohort and organized by IPFP scarring severity
| Full Cohort | ||||
|---|---|---|---|---|
| N (% female) | 28 (64%) | |||
| Age (years) | 66 ± 7 | |||
| Revision prior to imaging, N (%) | 5 (18%) | |||
| Revision after imaging, N (%) | 12 (43%) | |||
| Length of Implantation (years) | 4.9 ± 3.5 | |||
| Osteolysis, N (%) | 6 (21) | |||
| Synovitis, N (%) | 10 (36) | |||
| Joint effusion, N (%) | 4 (14) | |||
| Marrow edema, N (%) | 3 (11) | |||
| Fibrous membrane formation, N (%) | 3 (11) | |||
|
Distribution of Outcomes by IPFP scarring severity | ||||
| Variable | None | Mild | Moderate | Severe |
| N (% Female) | 3 (67) | 14 (79) | 4 (50) | 7 (43) |
| Age (years) | 65 ± 8 | 67 ± 6 | 66 ± 8 | 67 ± 8 |
| Revision prior to imaging, N (%) | 1 (33) | 2 (14) | 1 (25) | 1 (14) |
| Revision after imaging, N (%) | 2 (67) | 6 (43) | 2 (50) | 2 (29) |
| Length of Implantation (years) | 7.6 ± 1.0 | 4.2 ± 3.0 | 6.4 ± 1.0 | 4.4 ± 4.0 |
| Osteolysis, N (%) | 2 (67) | 2 (14) | 0 (0) | 2 (29) |
| Synovitis, N (%) | 2 (67) | 5 (36) | 1 (25) | 2 (29) |
| Joint effusion, N (%) | 0 (0) | 2 (14) | 0 (0) | 2 (29) |
| Marrow edema, N (%) | 0 (0) | 1 (7) | 1 (25) | 1 (14) |
| Fibrous membrane formation, N (%) | 0 (0) | 2 (14) | 0 (0) | 1 (14) |
Age and Length of Implantation expressed as mean ± SD